Literature DB >> 16369004

Two domains within the Mycoplasma hyopneumoniae cilium adhesin bind heparin.

Cheryl Jenkins1, Jody L Wilton, F Chris Minion, Linda Falconer, Mark J Walker, Steven P Djordjevic.   

Abstract

Mycoplasma hyopneumoniae is the causative agent of porcine enzootic pneumonia, a chronic and economically significant respiratory disease that affects swine production worldwide. M. hyopneumoniae adheres to and adversely affects the function of ciliated epithelial cells of the respiratory tract, and the cilium adhesin (Mhp183, P97) is intricately but not exclusively involved in this process. Although binding of pathogenic bacteria to glycosaminoglycans is a recognized step in pathogenesis, knowledge of glycosaminoglycan-binding proteins in M. hyopneumoniae is lacking. However, heparin and other sulfated polysaccharides are known to block the binding of M. hyopneumoniae to purified swine respiratory cilia. In this study, four regions within the cilium adhesin were examined for the ability to bind heparin. Cilium adhesin fragments comprising 653 amino acids of the N terminus and 301 amino acids of the C terminus (containing two repeat regions, R1 and R2) were cloned and expressed. These fragments bound heparin in a dose-dependent and saturable manner with physiologically significant binding affinities of 0.27 +/- 0.02 microM and 1.89 +/- 0.33 microM, respectively. Heparin binding of both fragments was strongly inhibited by the sulfated polysaccharides fucoidan and mucin but not by chondroitin sulfate B. When the C-terminal repeat regions R1 and R2 were cloned separately and expressed, heparin-binding activity was lost, suggesting that both regions are required for heparin binding. The ability of the cilium adhesin to bind heparin indicates that this molecule plays a multifunctional role in the adherence of M. hyopneumoniae to host respiratory surfaces and therefore has important implications with respect to the pathogenesis of this organism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16369004      PMCID: PMC1346629          DOI: 10.1128/IAI.74.1.481-487.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Identification of novel species-specific antigens of Mycoplasma hyopneumoniae by preparative SDS-PAGE ELISA profiling.

Authors:  Anthony L Scarman; James C Chin; Graeme J Earmens; Stephen F Delaney; Steven P Djordjevic
Journal:  Microbiology (Reading)       Date:  1997-02       Impact factor: 2.777

2.  Molecular analysis of the P97 cilium adhesin operon of Mycoplasma hyopneumoniae.

Authors:  T Hsu; F C Minion
Journal:  Gene       Date:  1998-07-03       Impact factor: 3.688

3.  Identification of the cilium binding epitope of the Mycoplasma hyopneumoniae P97 adhesin.

Authors:  T Hsu; F C Minion
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

4.  Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach.

Authors:  S Najjam; R V Gibbs; M Y Gordon; C C Rider
Journal:  Cytokine       Date:  1997-12       Impact factor: 3.861

5.  Characterization of the heparin-binding properties of human clusterin.

Authors:  G J Pankhurst; C A Bennett; S B Easterbrook-Smith
Journal:  Biochemistry       Date:  1998-04-07       Impact factor: 3.162

Review 6.  Sulfomucins in the human body.

Authors:  A V Nieuw Amerongen; J G Bolscher; E Bloemena; E C Veerman
Journal:  Biol Chem       Date:  1998-01       Impact factor: 3.915

7.  Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues.

Authors:  H Margalit; N Fischer; S A Ben-Sasson
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

8.  Demonstration that Australian Pasteurella multocida isolates from sporadic outbreaks of porcine pneumonia are non-toxigenic (toxA-) and display heterogeneous DNA restriction endonuclease profiles compared with toxigenic isolates from herds with progressive atrophic rhinitis.

Authors:  S P Djordjevic; G J Eamens; H Ha; M J Walker; J C Chin
Journal:  J Med Microbiol       Date:  1998-08       Impact factor: 2.472

9.  Reiterated repeat region variability in the ciliary adhesin gene of Mycoplasma hyopneumoniae.

Authors:  Jody L Wilton; Anthony L Scarman; Mark J Walker; Steven P Djordjevic
Journal:  Microbiology (Reading)       Date:  1998-07       Impact factor: 2.777

10.  Identification of a heparin-binding hemagglutinin present in mycobacteria.

Authors:  F D Menozzi; J H Rouse; M Alavi; M Laude-Sharp; J Muller; R Bischoff; M J Brennan; C Locht
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  24 in total

1.  Sequence TTKF ↓ QE defines the site of proteolytic cleavage in Mhp683 protein, a novel glycosaminoglycan and cilium adhesin of Mycoplasma hyopneumoniae.

Authors:  Daniel R Bogema; Nichollas E Scott; Matthew P Padula; Jessica L Tacchi; Benjamin B A Raymond; Cheryl Jenkins; Stuart J Cordwell; F Chris Minion; Mark J Walker; Steven P Djordjevic
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

2.  Mhp107 is a member of the multifunctional adhesin family of Mycoplasma hyopneumoniae.

Authors:  Lisa M Seymour; Linda Falconer; Ania T Deutscher; F Chris Minion; Matthew P Padula; Nicholas E Dixon; Steven P Djordjevic; Mark J Walker
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

3.  A processed multidomain mycoplasma hyopneumoniae adhesin binds fibronectin, plasminogen, and swine respiratory cilia.

Authors:  Lisa M Seymour; Ania T Deutscher; Cheryl Jenkins; Tracey A Kuit; Linda Falconer; F Chris Minion; Ben Crossett; Matthew Padula; Nicholas E Dixon; Steven P Djordjevic; Mark J Walker
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

4.  Mycoplasma bovis Membrane Protein MilA Is a Multifunctional Lipase with Novel Lipid and Glycosaminoglycan Binding Activity.

Authors:  Glenn Francis Browning; Kelly Anne Tivendale; James Yazah Adamu; Nadeeka Kumari Wawegama; Anna Kanci Condello; Marc Serge Marenda; Philip Francis Markham
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

5.  Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.

Authors:  F R Okamba; E Moreau; K Cheikh Saad Bouh; C A Gagnon; B Massie; M Arella
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

6.  RGD motif of lipoprotein T, involved in adhesion of Mycoplasma conjunctivae to lamb synovial tissue cells.

Authors:  Liza Zimmermann; Ernst Peterhans; Joachim Frey
Journal:  J Bacteriol       Date:  2010-05-21       Impact factor: 3.490

7.  Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA-attenuated Salmonella enterica Serovar Typhimurium.

Authors:  Jake N Matic; Tamsin D Terry; David Van Bockel; Tracy Maddocks; David Tinworth; Michael P Jennings; Steven P Djordjevic; Mark J Walker
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

Review 8.  Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.

Authors:  Dominiek Maes; Filip Boyen; Bert Devriendt; Peter Kuhnert; Artur Summerfield; Freddy Haesebrouck
Journal:  Vet Res       Date:  2021-05-08       Impact factor: 3.683

9.  Characterization of cleavage events in the multifunctional cilium adhesin Mhp684 (P146) reveals a mechanism by which Mycoplasma hyopneumoniae regulates surface topography.

Authors:  Daniel R Bogema; Ania T Deutscher; Lauren K Woolley; Lisa M Seymour; Benjamin B A Raymond; Jessica L Tacchi; Matthew P Padula; Nicholas E Dixon; F Chris Minion; Cheryl Jenkins; Mark J Walker; Steven P Djordjevic
Journal:  MBio       Date:  2012-04-03       Impact factor: 7.867

10.  Comparative genomic analyses of Mycoplasma hyopneumoniae pathogenic 168 strain and its high-passaged attenuated strain.

Authors:  Wei Liu; Shaobo Xiao; Mao Li; Shaohua Guo; Sha Li; Rui Luo; Zhixin Feng; Bin Li; Zhemin Zhou; Guoqing Shao; Huanchun Chen; Liurong Fang
Journal:  BMC Genomics       Date:  2013-02-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.